{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:33:17Z","timestamp":1790476397947,"version":"4.1.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021310","name":"Nigerian Institute of Medical Research","doi-asserted-by":"publisher","award":["NF-GMTP-24-152809"],"award-info":[{"award-number":["NF-GMTP-24-152809"]}],"id":[{"id":"10.13039\/501100021310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by persistent synovitis, systemic inflammation, and progressive joint damage. Medication and physical exercise are the most common interventions documented for the treatment of RA. The current systematic review examined the efficacy of pharmacological and physical exercise interventions for RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A systematic literature search utilized databases (PubMed, Web of Science, Google Scholar, Scopus, and CINAHL) to identify relevant randomized controlled trials (RCTs). The search strategy included keywords related to rheumatoid arthritis, pharmacological interventions, exercise therapy, and clinical outcomes. The review was registered with PROSPERO (CRD42024587378). Two independent reviewers screened the identified articles, and relevant data were extracted for analysis. The quality of evidence for the outcomes of interest in this systematic review and meta-analysis was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. Meta-analysis was carried out using a random-effects model. For the meta-analysis, we assessed the heterogeneity using the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighteen RCTs with a total sample size of 7,062 were included. Of these, eleven studies (61.11%) investigated the efficacy of different pharmacological interventions, whereas seven (38.89%) assessed the effects of exercise interventions. Different exercise programs showed improved functionality, reduced pain, and improved patient quality of life (QoL), while short- and medium-term sensorimotor trainings were reported. Pharmacological interventions also reported varying levels of reduction in disease activity and improved functionality. Pooled effects of four studies included in the meta-analysis revealed the different categories of incremental clinical outcomes (1.89, 2.46, and 2.63) after 24\u00a0months based on the American College of Rheumatology (ACR) criteria\u2014ACR 20, ACR 50, and ACR 70, respectively. Significant effect sizes (0.09 and \u22120.08) after 24\u00a0weeks were equally found in three studies, indicating the reduction in disease activity and an improvement in functionality, respectively. Despite robust efficacy data, a major limitation across the literature is the heterogeneity of reported ACR outcomes, attributable to pharmacological variation (immunogenicity and disease stage) rather than purely statistical bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pharmacological and physical exercise interventions benefit many patients with RA, particularly regarding clinical outcomes such as reduced disease activity and improved functional ability; and both interventions are potentially synergistic in RA. However, more RCTs are required, especially in Sub-Saharan Africa (SSA), to buttress the evidence base for these interventions. Crucially, the review notes the need for greater pharmacological discussion on safety and tolerability in future studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024587378<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1686128","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:18:56Z","timestamp":1763630336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of pharmacological interventions and therapeutic exercises for rheumatoid arthritis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Timothy","family":"Adeyemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitalis Ikenna","family":"Chukwuike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motunrayo Adebukunola","family":"Oladimeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuoma Shalom","family":"Ahwinahwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Ayodeji","family":"Ayeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha Adam","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmuminu","family":"Isah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Love Bukola","family":"Ayamolowo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluchukwu Perpetual","family":"Okeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olunike","family":"Abodunrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folahanmi","family":"Akinsolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olajide Odunayo","family":"Sobande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41584-021-00603-4","article-title":"Rheumatic diseases in Africa","volume":"17","author":"Adelowo","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/rheumatology\/ker330","article-title":"Efficacy of resistance exercises in rheumatoid arthritis: meta-analysis of randomized controlled trials","volume":"51","author":"Baillet","year":"2012","journal-title":"Rheumatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid. Synth."},{"key":"B5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nrrheum.2014.193","article-title":"Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation","volume":"11","author":"Benatti","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s10067-014-2691-2","article-title":"A systematic review into the effectiveness of hand exercise therapy in the treatment of rheumatoid arthritis","volume":"33","author":"Bergstra","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1136\/bjsports-2024-108369","article-title":"High-intensity interval training improves cardiovascular and physical health in patients with rheumatoid arthritis: a multicentre randomised controlled trial","volume":"58","author":"Bilberg","year":"2024","journal-title":"Br. J. sports Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/rheumatology\/keaa150","article-title":"A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis","volume":"59","author":"Boniface","year":"2020","journal-title":"Rheumatol. (United Kingdom)"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.21519","article-title":"The PREMIER study: a multicenter, randomized, double\u2010blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis & Rheumatism Official J. Am. Coll. Rheumatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/CEOR.S124381","article-title":"Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data","volume":"15","author":"Brodszky","year":"2017","journal-title":"Clin. Outcomes Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/jcm12041291","article-title":"The burden of rheumatoid arthritis: findings from the 2019 global burden of diseases study and forecasts for 2030 by bayesian age-period-cohort analysis","volume":"12","author":"Cai","year":"2023","journal-title":"J. Clin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00296-009-1090-5","article-title":"A systematic review of the effects of dynamic exercise in rheumatoid arthritis","volume":"30","author":"Cairns","year":"2009","journal-title":"Rheumatol. Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/rheumatology\/kew004","article-title":"Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohorts","volume":"55","author":"Carpenter","year":"2016","journal-title":"Rheumatology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3390\/healthcare11152123","article-title":"Physical exercise and occupational therapy at home to improve the quality of life in subjects affected by rheumatoid arthritis: a randomized controlled trial","volume":"11","author":"Cerasola","year":"2023","journal-title":"Healthc. (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s00296-013-2706-3","article-title":"Effectiveness of sensorimotor training in patients with rheumatoid arthritis: a randomized controlled trial","volume":"33","author":"Da Silva","year":"2013","journal-title":"Rheumatol. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e000404","DOI":"10.1136\/rmdopen-2016-000404","article-title":"Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis","volume":"3","author":"Daien","year":"2017","journal-title":"RMD Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.3390\/ijms24065643","article-title":"Rheumatic immune-related adverse events due to immune checkpoint inhibitors\u2014a 2023 update","volume":"24","author":"Dang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British society for rheumatology biologics register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7326\/0003-4819-148-2-200801150-00192","article-title":"Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis","volume":"148","author":"Donahue","year":"2008","journal-title":"Ann. Intern Med."},{"key":"B22","first-page":"395","article-title":"Cloaking malware with the trusted platform module","author":"Dunn","year":"2011"},{"key":"B23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341x.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","article-title":"Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial","volume":"372","author":"Emery","year":"2008","journal-title":"Lancet London, Engl."},{"key":"B26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.37526\/1526-744x.2024.51.4.393","article-title":"Exploring the evidence: generating a research question: using the PICOT framework for clinical inquiry","volume":"51","author":"Feldner","year":"2024","journal-title":"Nephrol. Nurs. J. J. Am. Nephrol. Nurses\u2019 Assoc."},{"key":"B27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/ard.2008.099291","article-title":"Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study","volume":"68","author":"Fleischmann","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(13)60250-0","article-title":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial","volume":"381","author":"Gabay","year":"2013","journal-title":"Lancet London, Engl."},{"key":"B29","first-page":"2398","article-title":"The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis","volume":"33","author":"Gartlehner","year":"2006","journal-title":"J. Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011279.pub2","article-title":"Physical activity and exercise for chronic pain in adults: an overview of Cochrane reviews","volume":"2017","author":"Geneen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/art.23940","article-title":"Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1136\/ard.2003.013003","article-title":"Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis: a 5 year follow up","volume":"63","author":"H\u00e4kkinen","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013562","article-title":"Disease\u2010modifying anti\u2010rheumatic drugs for rheumatoid arthritis: a systematic review and network meta\u2010analysis","author":"Hazlewood","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jan.14574","article-title":"The effect of physical exercise on rheumatoid arthritis: an overview of systematic reviews and meta\u2010analysis","volume":"77","author":"Hu","year":"2021","journal-title":"J. Adv. Nurs."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/rheumatology\/kead525","article-title":"Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases","volume":"63","author":"Jyssum","year":"2024","journal-title":"Rheumatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3390\/jcm14062107","article-title":"Abatacept, golimumab, and Sarilumab as selected bio-originator disease-modifying antirheumatic drugs with diverse mechanisms of action in their current use in treatment","volume":"14","author":"Kawczak","year":"2025","journal-title":"J. Clin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"S744","DOI":"10.1136\/annrheumdis-2019-216656","article-title":"Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis","volume":"79","author":"Kerschbaumer","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial","volume":"144","author":"Kremer","year":"2006","journal-title":"Ann. Intern Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4137\/CMAMD.S5558","article-title":"Pharmacotherapy options in rheumatoid arthritis","volume":"6","author":"Kumar","year":"2013","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00019053-200422001-00002","article-title":"Epidemiology and burden of illness of rheumatoid arthritis","volume":"22","author":"Kvien","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0140-6736(14)60998-3","article-title":"Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial","volume":"385","author":"Lamb","year":"2015","journal-title":"Lancet London, Engl."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/art.24891","article-title":"Effects of high\u2010intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial","volume":"61","author":"Lemmey","year":"2009","journal-title":"Arthritis Care & Res."},{"key":"B49","volume-title":"SDG 3: ensure healthy lives and promote well-being for all at all ages","author":"Long","year":"2022"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1177\/0269215517698732","article-title":"Effectiveness of an overall progressive resistance strength program for improving the functional capacity of patients with rheumatoid arthritis: a randomized controlled trial","volume":"31","author":"Lourenzi","year":"2017","journal-title":"Clin. Rehabil."},{"key":"B51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semarthrit.2014.05.001","article-title":"The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis","volume":"44","author":"Matcham","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"B52","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.berh.2019.03.013","article-title":"Physical activity, exercise and rheumatoid arthritis: effectiveness, mechanisms and implementation","volume":"32","author":"Metsios","year":"2018","journal-title":"Best Pract. & Res. Clin. rheumatology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1136\/annrheumdis-2016-210713","article-title":"Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"76","author":"Nam","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/art.20303","article-title":"Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial","volume":"50","author":"Nishimoto","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B55","first-page":"S115","article-title":"7th congress of the African league of associations for rheumatology (AFLAR) & 23rd congress of the South African rheumatism and Arthritis Association (SARAA)","volume":"32","author":"Organisers","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e000713","DOI":"10.1136\/rmdopen-2018-000713","article-title":"Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip\/knee osteoarthritis","volume":"4","author":"Osthoff","year":"2018","journal-title":"RMD open"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/cphy.c120033","article-title":"Muscle as a secretory organ","volume":"3","author":"Pedersen","year":"2013","journal-title":"Compr. Physiol."},{"key":"B58","first-page":"241","volume-title":"Analysing data and undertaking meta analyses","author":"Points","year":"2019"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e35462","DOI":"10.2196\/35462","article-title":"An exercise and educational and self-management Program delivered with a smartphone app (CareHand) in adults with rheumatoid arthritis of the hands: randomized controlled trial","volume":"10","author":"Rodr\u00edguez S\u00e1nchez-Laulh\u00e9","year":"2022","journal-title":"JMIR mHealth uHealth"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e001512","DOI":"10.1136\/rmdopen-2020-001512","article-title":"Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis","volume":"7","author":"Roodenrijs","year":"2021","journal-title":"RMD Open"},{"key":"B61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5114\/reum.2021.107026","article-title":"Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and meta-analysis of clinical trial studies","volume":"59","author":"Saki","year":"2021","journal-title":"Reumatologia\/rheumatology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/annrheumdis-2013-203843","article-title":"Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial","volume":"73","author":"Schiff","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/ard-2022-223357","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"82","author":"Sepriano","year":"2023","journal-title":"Ann. rheumatic Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet London, Engl."},{"key":"B65","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/ard.2008.101659","article-title":"Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial","volume":"68","author":"Smolen","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"B66","first-page":"685","volume-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological modifying antirheumatic drugs: 2019 update","author":"Smolen","year":"2020"},{"key":"B67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/14397595.2021.1886653","article-title":"Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthritis","volume":"32","author":"Sobue","year":"2022","journal-title":"Mod. Rheumatol."},{"key":"B68","first-page":"S32","article-title":"The impact of rheumatoid arthritis and treatment on patients\u2019 lives","volume":"28","author":"Strand","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/ard-2023-224912","article-title":"Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial","volume":"83","author":"Teuwen","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/art.22339","article-title":"Using internet technology to deliver a home-based physical activity intervention for patients with rheumatoid arthritis: a randomized controlled trial","volume":"55","author":"Van Den Berg","year":"2006","journal-title":"Arthritis Care Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0140-6736(09)60944-2","article-title":"Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial","volume":"374","author":"van Vollenhoven","year":"2009","journal-title":"Lancet London, Engl."},{"key":"B72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ebiom.2017.07.023","article-title":"Muscle weakness in rheumatoid arthritis: the role of Ca2 + and free radical signaling","volume":"23","author":"Yamada","year":"2017","journal-title":"EBioMedicine"},{"key":"B73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13102-022-00408-2","article-title":"Effectiveness and safety of aerobic exercise for rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Ye","year":"2022","journal-title":"BMC Sports Sci. Med. Rehabil."},{"key":"B74","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.pmn.2018.07.007","article-title":"Relations among pain, pain beliefs, and psychological well-being in patients with chronic pain","volume":"19","author":"Yildizeli Topcu","year":"2018","journal-title":"Pain Manag. Nurs."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1686128\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:19:04Z","timestamp":1763630344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1686128\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":74,"alternative-id":["10.3389\/fphar.2025.1686128"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1686128","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1686128"}}